Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sirnaomics Ltd. ( (HK:2257) ) has provided an announcement.
Sirnaomics Ltd. announced that Dr. Poon Hung Fai, the company’s chairman and executive director, has increased his shareholding by purchasing 100,000 ordinary shares at an average price of HK$6.83 per share. This move reflects Dr. Poon’s confidence in the company’s growth prospects and potential development. The acquisition raises his total shareholding to 16.44% of the company’s issued share capital, signaling strong insider confidence, which may positively influence investor sentiment.
The most recent analyst rating on (HK:2257) stock is a Hold with a HK$7.50 price target. To see the full list of analyst forecasts on Sirnaomics Ltd. stock, see the HK:2257 Stock Forecast page.
More about Sirnaomics Ltd.
Sirnaomics Ltd. is a biotechnology company focused on the development of RNAi therapeutics for the treatment of various diseases. The company operates in the pharmaceutical industry, aiming to leverage RNA interference technology to address unmet medical needs.
Average Trading Volume: 742,799
Technical Sentiment Signal: Sell
Current Market Cap: HK$736.1M
Learn more about 2257 stock on TipRanks’ Stock Analysis page.